Aurinia Pharmaceuticals Inc

NASDAQ:AUPH   1:08:46 PM EDT
4.72
-0.20 (-3.97%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)670.06M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$28.33 Million
Adjusted EPS-$0.28
See more estimates
10-Day MA$4.92
50-Day MA$6.38
200-Day MA$9.39
See more pivots

Aurinia Pharmaceuticals Inc Stock, NASDAQ:AUPH

4464 Markham Street, Suite 1203, Victoria, British Columbia V8Z 7X8
Canada
Phone: +1.250.744.2487
Number of Employees: 300

Description

Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.